New York, NY—June 12, 2018
For nine years in a row, Hospital for Special Surgery (HSS) has an infection rate that is significantly lower than the New York State average for hip replacement or revision surgeries, according to the 2016 report on hospital infection rates that was just released by the State Department of Health.
"Patients must consider multiple factors when choosing a surgical care provider including a center’s infection rate," said Louis A. Shapiro, president and CEO at HSS. "We believe that our unwavering focus on infection control at every stage of contact is why HSS continues to maintain a very low infection rate compared to other hospitals."
Surgeons at HSS performed the most hip replacement surgeries in New York State, with nearly 5,337 procedures, which is about 16 percent of the approximate 33,723 hip replacement or revision procedures in New York State in 2016. Among the 157 hospitals included in the report, HSS has consistently performed better than our peers for total hip replacement or revision hip procedures.
"HSS performs more than 30,000 surgical procedures a year and we’re constantly finding ways to measure and improve our best practices to deliver the highest quality musculoskeletal care," said Todd J. Albert, MD, surgeon-in-chief and medical director at HSS. "We pioneered the use of regional anesthesia, a technique that reduces the chance of a surgical infection by 50 percent."
Specialization in orthopedic surgery allows HSS to improve efficiency in surgical settings within each operating room, lowering surgical times and improving safety. Numerous best practices include uniquely-designed operating rooms equipped with Plexiglas separation panels and high-tech air filtration systems; enhanced sterilization methods; disciplined staff infection control practices; patient education; and post-surgery, the operating rooms are meticulously cleaned above mandated protocols.
"Our perioperative teams are dedicated to working collaboratively in the operating room to improve efficiency and going the extra mile to limit infection risk for each and every patient," explained Eileen Finerty, RN, assistant vice president of Infection Control and Occupational Health.
New York State’s strict regulatory and surveillance systems require hospitals to report certain hospital-acquired infections to the State Department of Health. This year’s publication is the 10th report of hospital-acquired infections in New York State, but the 9th report to include hip replacement procedures. The report states that the data are made publically available each year to give people information about hospital performance that could help them make informed medical decisions.
View the full report from the New York State Department of Health at: https://www.health.ny.gov/statistics/facilities/hospital/hospital_acquired_infections/2016/docs/hospital_acquired_infection_p1.pdf
See HSS initiatives towards providing the highest quality healthcare at: http://www.hss.edu/quality
About HSS | Hospital for Special Surgery
HSS is the world’s leading academic medical center focused on musculoskeletal health. At its core is Hospital for Special Surgery, nationally ranked No. 1 in orthopedics (for the ninth consecutive year) and No. 3 in rheumatology by U.S.News & World Report (2018-2019). Founded in 1863, the Hospital has one of the lowest infection rates in the country and was the first in New York State to receive Magnet Recognition for Excellence in Nursing Service from the American Nurses Credentialing Center four consecutive times. The global standard total knee replacement was developed at HSS in 1969. An affiliate of Weill Cornell Medical College, HSS has a main campus in New York City and facilities in New Jersey, Connecticut and in the Long Island and Westchester County regions of New York State. In 2017 HSS provided care to 135,000 patients and performed more than 32,000 surgical procedures. People from all 50 U.S. states and 80 countries travelled to receive care at HSS. In addition to patient care, HSS leads the field in research, innovation and education. The HSS Research Institute comprises 20 laboratories and 300 staff members focused on leading the advancement of musculoskeletal health through prevention of degeneration, tissue repair and tissue regeneration. The HSS Global Innovation Institute was formed in 2016 to realize the potential of new drugs, therapeutics and devices. The culture of innovation is accelerating at HSS as 130 new idea submissions were made to the Global Innovation Institute in 2017 (almost 3x the submissions in 2015). The HSS Education Institute is the world’s leading provider of education on the topic on musculoskeletal health, with its online learning platform offering more than 600 courses to more than 21,000 medical professional members worldwide. Through HSS Global Ventures, the institution is collaborating with medical centers and other organizations to advance the quality and value of musculoskeletal care and to make world-class HSS care more widely accessible nationally and internationally.